GAM
GILD icon

Grandview Asset Management’s Gilead Sciences GILD Stock Holding History

Grandview Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-306
Closed -$20K – 236
2021
Q1 		$20K Buy
+306
New +$19.7K 0.01% 280
2020
Q4 		– Sell
-11,300
Closed -$714K – 118
2020
Q3 		$714K Sell
11,300
-3,900
-26% -$270K 0.58% 49
2020
Q2 		$1.17M Buy
+15,200
New +$1.16M 1.02% 34

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Grandview Asset Management's GILD Position: Q2 2021 in Review

Grandview Asset Management sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 306 shares — an estimated $20K sold.

Grandview Asset Management first reported a position in GILD in Q2 2020 and held it in 3 quarters. The position peaked at $1.17M in Q2 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Grandview Asset Management reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Grandview Asset Management sold 306 Gilead Sciences shares in Q2 2021, an estimated $20K.
  • Grandview Asset Management first reported a position in Gilead Sciences in Q2 2020 and held it in 3 quarters.
  • Grandview Asset Management's Gilead Sciences position peaked at $1.17M in Q2 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.